Renaissance Technologies - ELEDON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$85
+2.4%
61,973
+2.7%
0.00%
Q2 2023$83
+9.2%
60,373
+87.7%
0.00%
Q1 2023$76
+11.8%
32,173
+8.4%
0.00%
Q4 2022$68
-99.9%
29,673
-6.9%
0.00%
Q3 2022$88,000
+11.4%
31,873
-0.9%
0.00%
Q2 2022$79,000
+8.2%
32,173
+74.2%
0.00%
Q1 2022$73,000
+21.7%
18,473
+35.1%
0.00%
Q4 2021$60,000
-75.5%
13,673
-65.5%
0.00%
Q3 2021$245,000
+46.7%
39,663
+87.9%
0.00%
Q2 2021$167,000
-42.2%
21,107
-22.0%
0.00%
Q1 2021$289,00027,0510.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CM Management, LLC 234,803$321,6800.34%
BVF INC/IL 4,326,710$5,927,5930.16%
ARMISTICE CAPITAL, LLC 1,824,000$2,498,8800.04%
SVB FINANCIAL GROUP 13,472$18,4570.04%
JMAC ENTERPRISES LLC 58,041$79,5160.02%
Woodline Partners LP 603,993$827,4700.01%
INGALLS & SNYDER LLC 51,849$710.00%
Ensign Peak Advisors, Inc 443,001$606,9110.00%
MILLENNIUM MANAGEMENT LLC 27,150$37,1960.00%
Curi RMB Capital, LLC 10,000$13,7000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders